Laparoscopic and robotic postchemotherapy retroperitoneal lymph node dissection

Curr Opin Urol. 2014 Mar;24(2):162-7. doi: 10.1097/MOU.0000000000000028.

Abstract

Purpose of review: Open surgical postchemotherapy retroperitoneal lymph node dissection remains the standard of care. On the contrary, laparoscopy is an emerging technique and reports of laparoscopic lymph node dissection postchemotherapy are increasing. Our purpose is to present indications, technique and outcomes of laparoscopic postchemo retroperitoneal lymph node dissection.

Recent findings: With growing expertise and knowledge the morbidity of the laparoscopic approach is much reduced compared with open surgery with the same oncological outcome. Robotic surgery is a more recent approach with growing usage in urology. However, no reports of robotic postchemotherapy lymph node dissection are available.

Summary: In expert hands laparoscopic lymph node dissection is a feasible technique, offering less morbidity to patients with good oncological results.

Publication types

  • Review

MeSH terms

  • Chemotherapy, Adjuvant
  • Humans
  • Laparoscopy* / adverse effects
  • Lymph Node Excision / adverse effects
  • Lymph Node Excision / methods*
  • Lymphatic Metastasis
  • Male
  • Neoadjuvant Therapy*
  • Neoplasm Staging
  • Neoplasms, Germ Cell and Embryonal / secondary
  • Neoplasms, Germ Cell and Embryonal / therapy*
  • Retroperitoneal Space
  • Robotics*
  • Surgery, Computer-Assisted* / adverse effects
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / therapy*
  • Treatment Outcome